RxSight, Inc. cotiza a 4.53 USD y tiene una capitalización bursátil de $188M. En los últimos 12 meses ha facturado $128M con un margen de flujo de caja libre del -14.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients a…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.11 | $-0.19 | $-0.03 |
| Estimado | $-0.19 | $-0.19 | $-0.15 | $-0.20 |
| Sorpresa | — | +42.1% | -26.7% | +85.0% |
| Métrica | RXST | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 76.6% | 57.0% | +19.6% |
| Operating Margin | -35.8% | -38.6% | +2.8% |
| Net Margin | -29.0% | -33.6% | +4.6% |
| FCF Margin | -14.4% | -13.9% | -0.5% |
| ROE | -14.1% | -40.4% | +26.3% |
| ROA | -12.5% | -32.0% | +19.5% |
| Current Ratio | 10.95 | 2.84 | +8.11 |
| Debt / Equity | — | 0.28 | — |